De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017Giuseppe Curigliano, Andrew Tutt, Harold J. Burstein et al.|Annals of Oncology|2017Cited by 1.3k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesNasim Mavaddat, Christine L. Clarke, Irene L. Andrulis et al.|The American Journal of Human Genetics|2018Cited by 1.2k
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021Harold J. Burstein, Binghe Xu, Giuseppe Curigliano et al.|Annals of Oncology|2021Cited by 799
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysisFrançois‐Clément Bidard, Paul Cottu, Stefan Michiels et al.|JNCI Journal of the National Cancer Institute|2018Cited by 282
Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023Giuseppe Curigliano, Marleen Kok, B. Xu et al.|Annals of Oncology|2023Cited by 218